Photothermal therapy of tuberculosis using targeting pre-activated macrophage membrane-coated nanoparticles
B Li, W Wang, L Zhao, Y Wu, X Li, D Yan, Q Gao… - Nature …, 2024 - nature.com
Conventional antibiotics used for treating tuberculosis (TB) suffer from drug resistance and
multiple complications. Here we propose a lesion–pathogen dual-targeting strategy for the …
multiple complications. Here we propose a lesion–pathogen dual-targeting strategy for the …
Advancing tuberculosis management: the role of predictive, preventive, and personalized medicine
Tuberculosis is a major global health issue, with approximately 10 million people falling ill
and 1.4 million dying yearly. One of the most significant challenges to public health is the …
and 1.4 million dying yearly. One of the most significant challenges to public health is the …
Pharmacogenetics as part of recommended precision medicine for tuberculosis treatment in African populations: Could it be a reality?
C Oelofse, CAA Ndong Sima… - Clinical and …, 2023 - Wiley Online Library
Globally, tuberculosis (TB) is the second most lethal infectious disease. However, in sub‐
Saharan Africa, TB has the largest disease burden, with drug‐resistant TB increasingly …
Saharan Africa, TB has the largest disease burden, with drug‐resistant TB increasingly …
[HTML][HTML] Pharmacogenetic Study of Drugs Affecting Mycobacterium tuberculosis
S Shabani, P Farnia, J Ghanavi… - The International …, 2024 - journals.lww.com
Background: Pharmacogenetic research has led to significant progress in understanding
how genetic factors influence drug response in tuberculosis (TB) treatment. One ongoing …
how genetic factors influence drug response in tuberculosis (TB) treatment. One ongoing …